Delivery Order SPE2DB20D3101-SPE2DB25FQYC9
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,351.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,175,621 units of Ondansetron ODT 4 mg tablets. It is a firm-fixed-price delivery order with a completion date of July 18, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $5,178.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,566,307,493 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of November 4, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,902.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,322,640 units of the drug Ondansetron ODT 4 mg tablets, with a completion date of November 5, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,893.31 firm-fixed-price delivery order is for the supply of 4,566,553,998 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of November 27, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Ondansetron ODT 4 mg tablets. The contract has a total ceiling value of $5,615.65 and a performance period through April 2024. It is a firm fixed-price delivery order contract, without any set-aside designation.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,402.67 firm fixed-price delivery order contract is for the supply of 4,563,755,906 units of 4 mg Ondansetron HCl tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of February 26, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,437.15 firm-fixed-price delivery order contract is for the supply of 4,566,529,767 units of Ondansetron ODT 4 mg tablets. This contract has an ultimate completion date of November 25, 2024 and is not designated with any set-aside requirements, indicating open competition.
Amerisourcebergen holds a significant...
This federal contract award, valued at $40,263.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,566,769,751 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of December 20, 2024.
Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,871.39 delivery order contract is for the provision of 4,566,518,639 ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 22, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $11,502.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,565,562,970 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of August 26, 2024.
Amerisourcebergen holds a significant...